Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Confluence Life Sciences is focused on rational drug designs to develop novel kinase inhibitors for use in human and animal healthcare.
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy.
Antegrin Therapeutics is a Biotechnology company located in 4320 Forest Park Ave., Ste. 304, St. Louis, MO, United States.
GeneriCo is a generic drug company developing and marketing generic pharmaceuticals in the U.S.
Video Fizz is a Missouri-based startup
SynerZ Medical is a medical device company providing treatment for obesity and type 2 diabetes.
Missouri Technology Corporation has invested in 54 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Missouri Technology Corporation's top investment sectors include Biotechnology, Health Care, Life Science, Therapeutics, Medical. The firm invests across 12 different industry categories.
Among tracked funding rounds, Confluence Life Sciences received $4.8M in a Series Unknown round. Missouri Technology Corporation's total known invested capital is $61.2M.
Missouri Technology Corporation's average investment size is $1.7M across its portfolio of 54 companies.